Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593854 | SCV000708611 | uncertain significance | not provided | 2017-05-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001037560 | SCV001200979 | uncertain significance | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with tryptophan at codon 543 of the MKS1 protein (p.Arg543Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs748406509, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with MKS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 502021). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV005027716 | SCV005649595 | uncertain significance | Bardet-Biedl syndrome 13; Meckel syndrome, type 1; Joubert syndrome 28 | 2024-04-24 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001829682 | SCV002087601 | uncertain significance | Meckel syndrome, type 1 | 2019-10-28 | no assertion criteria provided | clinical testing |